Navigation Links
Mentor Licenses Botulinum From WARF and Plans Wisconsin Manufacturing Facility

MADISON, Wis. - The Wisconsin Alumni Research Foundation (WARF) has completed a licensing agreement with Mentor Corporationa California-based publicly traded company (NYSE: MNT), which gives Mentor the exclusive manufacturing and marketing rights to the proprietary botulinum ......

Full article >>> how. We expect to begin clinical testing of a cosmetic product in the coming year. We have a next generation product that is considerably purer than currently available toxins. A purer neurotoxin is expected to reduce dosage requirements and adverse reactions."

According to the American Society of Plastic Surgeons, over one million people were treated with botulinum toxin in 2002, making......

Full article >>>
'"/>

Source:wistechnology.com By Mike Klein 12/15/03


Related biology technology :

1. Inacom Supports Blackhawk Technology Mentor Program
2. PKWARE Licenses Technology to Expand SecureZIP Standard
3. Entrepreneurs and Business Plans
4. Governor Doyle Plans To Increase Web Access
5. To be a player in the "Knowledge Economy," Wisconsin needs more tech workers
6. Federal bioenergy lab will give Wisconsin a chance to shine
7. Breaking down Wisconsins angel capital numbers
8. Innovation featured in NE Wisconsin Roundtable
9. Visions: Broderick says Wisconsin should be in top third in venture capital
10. Wisconsin building toward the major leagues of venture capital
11. Wisconsin Supreme Court to hear Menasha software case
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/23/2016)... , June 23, 2016 Houston ... with the Cy-Fair Sports Association to serve as ... the agreement, Houston Methodist Willowbrook will provide sponsorship ... and connectivity with association coaches, volunteers, athletes and ... with the Cy-Fair Sports Association and to bring ...
(Date:6/23/2016)... 23, 2016   EpiBiome , a precision microbiome ... in debt financing from Silicon Valley Bank (SVB). The ... to advance its drug development efforts, as well as ... "SVB has been an incredible strategic partner to ... traditional bank would provide," said Dr. Aeron Tynes ...
(Date:6/23/2016)... 23, 2016 Apellis Pharmaceuticals, Inc. today ... trials of its complement C3 inhibitor, APL-2. The ... ascending dose studies designed to assess the safety, ... injection in healthy adult volunteers. Forty ... a single dose (ranging from 45 to 1,440mg) ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... the Pennsylvania Convention Center and will showcase its product’s latest features from June ... be presenting a scientific poster on Disrupting Clinical Trials in The Cloud during ...
Breaking Biology Technology:
(Date:6/1/2016)... YORK , June 1, 2016 ... Technology in Election Administration and Criminal Identification to Boost ... to a recently released TechSci Research report, " Global ... By Region, Competition Forecast and Opportunities, 2011 - 2021", ... 24.8 billion by 2021, on account of growing security ...
(Date:5/12/2016)... , May 12, 2016 WearablesResearch.com , ... published the overview results from the Q1 wave of ... recent wave was consumers, receptivity to a program where ... with a health insurance company. "We were ... share," says Michael LaColla , CEO of Troubadour ...
(Date:4/28/2016)... GOTHENBURG, Sweden , April 28, 2016 ... 1,491.2 M (139.9), up 966% compared with the first quarter of ... Operating profit totaled SEK 589.1 M (loss: 18.8) and the operating ... SEK 7.12 (loss: 0.32) Cash flow from operations was ... , The 2016 revenue guidance is unchanged, SEK 7,000-8,500 M. ...
Breaking Biology News(10 mins):